Increasingly strict regulatory controls governing clinical research pose a severe threat to the development of new cancer medicines for children, and may jeopardize recent improvements in survival, according to a special edition of Lancet Oncology.
News
Advertisement
The FDA has released its plan for pre-dementia Alzheimer's trials.
Advertisement
Constant technological advancements continue to alter the compliance battle.
How one eClinical platform can create unparalleled efficiency in the future.
Advertisement
Path to Patient Drug Compliance in Clinical Trials. Podcast slideshow interview with Tony Frankland, Global Head of Sales and Marketing Cenduit
Advertisement
Lisa Henderson interview Gerd Arold or PRA about patient recruitment factors in early phase trials
Lisa Henderson interviews Gerd Arold of PRA about patient enrollment in early phase trials in Eastern Europe
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Gilead’s ARTISTRY-2 Trial Shows Bictegravir Lenacapavir Combo Matches Biktarvy in Virologically Suppressed Adults With HIV
2
When AI Learns to Speak Every Language: An eCOA Migration Study
3
Upskilling Community Cancer Centers: A Training Pilot Hints at Promising Ways to Boost Oncology Clinical Research
4
Using Digital Tools to Enhance Patient-Centric Trials
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
